Importance of periodontal disease in the kidney patient

Blood Purification

Volumn 20, Issue 1, 2002, Pages 113-119

  Craig, Ronald G ^a   Spittle, Margaret A ^b   Levin, Nathan W ^c  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; C reactive protein; Inflammation; Myocardial infarction; Periodontal diseases; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE;

ACUTE DISEASE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; LIVER LEVEL; MEDICAL ASSESSMENT; MORTALITY; MOUTH INFECTION; PERIODONTAL DISEASE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; ACUTE PHASE RESPONSE; ARTERIOSCLEROSIS; BLOOD; CHRONIC KIDNEY FAILURE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

ACUTE-PHASE REACTION; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; HUMAN; INFLAMMATION; KIDNEY FAILURE, CHRONIC; PERIODONTAL DISEASES; RENAL DIALYSIS; SUPPORT, U.S. GOV'T, P.H.S.; HUMANS;

EID: 0036007334     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046994     Document Type: Article

References (72)

1. Excerpts from the USRDS 1998 Annual Data Report. Patient mortality and survival
2. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
3. Periodontitis: A risk factor for coronary heart disease?
4. The protective nature of host responses in periodontal diseases
5. Microbial etiological agents of destructive periodontal diseases
6. Microbiota of health, gingivitis and initial periodontitis
7. The capacity of Actinobacillus actinomycetemcomitans, Bacteroides gingivalisand Bacteroides intermediusto indicate progressive periodontitis: A retrospective study
8. The predominant cultivatable microbiota of active and inactive lesions of destructive periodontitis
9. The microflora of periodontal sites showing active disease progression
10. Microbial complexes in dental plaque
11. Clinical risk factors for periodontal attachment loss
12. Serum IgG antibody response to periodontal pathogens in minority populations: Relationship to periodontal disease status and progression
13. Acute-phase reactants in infections and inflammatory diseases
14. Oral disease, cardiovascular disease and systemic inflammation
15. Age, dental infections, and coronary heart disease
16. Association between dental health and acute myocardial infarction
17. Dental infections and atherosclerosis
18. Association between acute cerebrovascular ischemia and chronic and recurrent infection
19. Dental infection and risk of new coronary artery disease
20. Dental disease and risk of coronary heart disease and mortality
21. Poor oral health and coronary heart disease
22. Periodontal disease and cardiovascular disease
23. Association between extent of periodontal attachment loss and self-reported history of heart attack: An analysis of NHANES III data
24. Periodontal infection as a possible risk factor for preterm low birth weight
25. Periodontal disease experience in adult long-duration insulin-dependent diabetics
26. Periodontal conditions in insulin-dependent diabetes mellitus
27. A longitudinal study on insulin-dependent diabetes mellitus and periodontal disease
28. The relation between clinical periodontal status and insulin-dependent diabetes mellitus
29. Type 2 diabetes mellitus and periodontal disease
30. Periodontal disease and NIDDM in Pima Indians
31. Periodontal disease in non-insulin-dependent diabetes mellitus
32. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus
33. Glycemic control and alveolar bone loss progression in type 2 diabetes
34. Treatment of periodontal disease in diabetics reduces glycated hemoglobin
35. Plasma lipid and blood glucose levels in patients with destructive periodontal disease
36. Cytokines and the hepatic acute phase response
37. Acute-phase inflammatory response to periodontal disease in the US population
38. Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins
39. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients
40. Dental infections in association with cerebral infarction in young and middle-aged men
41. The relationship between dental disease and cerebral vascular accidents in elderly United States veterans
42. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis
43. Initiation of acute phase response and synthesis of cytokines
44. Acute-phase proteins and other systemic responses to inflammation
45. Acute-phase reactants in infections and inflammatory diseases
46. Interleukin-8 can mediate acute-phase protein production by isolated hepatocytes
47. Plasma concentrations of C-reactive protein and risk of developing peripheral vascular disease
48. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
49. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results for the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg cohort study, 1984-1992
50. Production of C-reactive protein and risk of coronary events in stable and unstable angina
51. 2 as an independent predictor of coronary heart disease
52. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
53. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
54. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
55. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project
56. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
57. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
58. Biology and significance of C-reactive protein in cardiovascular and renal disease
59. Serum C-reactive protein and risk of death in chronic dialysis patients
60. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
61. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
62. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine
63. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component
64. Interactions of carbohydrates and lectins
65. A review of the biological properties of C-reactive protein
66. Binding site on human C-reactive protein (CRP) recognized by the leukocyte CRP receptor
67. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens
68. C-reactive protein binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region
69. The effect of human C-reactive protein on the cell-attachment activity of fibronectin and laminin
70. C-reactive protein co-localizes with complement in human hearts during acute myocardial infarction
71. The oral health status of individuals on renal dialysis